Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
Clinical trial NCT05698329 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05698329
- Sponsor
- AiViva BioPharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2025-03-03
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.